Myhre Peder L, Tromp Jasper, Ouwerkerk Wouter, Ting Daniel S W, Docherty Kieran F, Gibson C Michael, Lam Carolyn S P
Department of Cardiology, Akershus University Hospital, Lørenskog, Norway; KG Jebsen Center for Cardiac Biomarkers, University of Oslo, Oslo, Norway.
National Heart Centre Singapore, Singapore; Duke-National University of Singapore, Singapore; Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
Lancet Digit Health. 2024 Oct;6(10):e755-e766. doi: 10.1016/S2589-7500(24)00158-4. Epub 2024 Aug 29.
This Series paper provides an overview of digital tools in heart failure care, encompassing screening, early diagnosis, treatment initiation and optimisation, and monitoring, and the implications these tools could have for research. The current medical environment favours the implementation of digital tools in heart failure due to rapid advancements in technology and computing power, unprecedented global connectivity, and the paradigm shift towards digitisation. Despite available effective therapies for heart failure, substantial inadequacies in managing the condition have hindered improvements in patient outcomes, particularly in low-income and middle-income countries. As digital health tools continue to evolve and exert a growing influence on both clinical care and research, establishing clinical frameworks and supportive ecosystems that enable their effective use on a global scale is crucial.
本系列论文概述了心力衰竭护理中的数字工具,涵盖筛查、早期诊断、治疗启动与优化以及监测,以及这些工具对研究可能产生的影响。由于技术和计算能力的快速进步、前所未有的全球连通性以及向数字化的范式转变,当前的医疗环境有利于在心力衰竭中实施数字工具。尽管有有效的心力衰竭治疗方法,但在管理该疾病方面的严重不足阻碍了患者预后的改善,尤其是在低收入和中等收入国家。随着数字健康工具不断发展并对临床护理和研究产生越来越大的影响,建立能够在全球范围内有效使用这些工具的临床框架和支持性生态系统至关重要。